Post-Marketing Surveillance of Levofloxacin 0.5% Ophthalmic Solution for External Ocular Infections
Drugs in R and D - United Kingdom
doi 10.2165/11636020-000000000-00000
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2012
Authors
Publisher
Springer Science and Business Media LLC